Zobrazeno 1 - 10 of 110 pro vyhledávání: '"Irrissuto C"'
1
Akademický článek
The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3-ITD-Mutant Acute Myeloid Leukaemia.
Autor: Zicari S; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Merlino G; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Paoli A; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Fiascarelli A; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Tunici P; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Bisignano D; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Belli F; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Irrissuto C; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Talucci S; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Cirigliano E; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Iannitto ML; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Bigioni M; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Bressan A; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Brzózka K; Ryvu Therapeutics, Krakow, Poland., Ghiaur G; Division of Hematological Malignancies, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bellarosa D; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy., Binaschi M; Menarini Group, Preclinical and Translational Sciences, Pomezia, Rome, Italy.
Publikováno v: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Dec; Vol. 28 (23), pp. e70235.
Zobrazit plný text záznamu
2
Akademický článek
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
Autor: Fiascarelli A; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy. afiascarelli@menarini-ricerche.it., Merlino G; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Capano S; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Talucci S; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Bisignano D; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Bressan A; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Bellarosa D; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Carrisi C; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Paoli A; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Bigioni M; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Tunici P; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Irrissuto C; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Salerno M; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy., Arribas J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Preclinical and Translational Research Program Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, 28029, Monforte de Lemos, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona, Campus de la UAB, 08193, Barcelona, Bellaterra, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), 08010, Barcelona, Spain., de Stanchina E; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scaltriti M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Binaschi M; Menarini Group, Preclinical and Translational Sciences, Menarini Ricerche SpA, Via Tito Speri 10, 00071, Pomezia, Rome, Italy.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 May; Vol. 199 (1), pp. 13-23. Date of Electronic Publication: 2023 Mar 13.
Zobrazit plný text záznamu
3
Akademický článek
Comparison between Substance P and Calcitonin Gene-Related Peptide and Their Receptors in Colorectal Adenocarcinoma.
Autor: Șerban, Robert-Emmanuel1,2 (AUTHOR) drrobert.serban03@gmail.com, Boldeanu, Mihail Virgil3 (AUTHOR), Florescu, Dan Nicolae1,2 (AUTHOR) cristin.vere@umfcv.ro, Ionescu, Mihaela4 (AUTHOR) mihaela.ionescu@umfcv.ro, Șerbănescu, Mircea-Sebastian4 (AUTHOR), Boldeanu, Lidia5 (AUTHOR) mihaela.ionescu@umfcv.ro, Florescu, Mirela-Marinela6 (AUTHOR), Stepan, Mioara-Desdemona7 (AUTHOR), Obleagă, Vasile-Cosmin8 (AUTHOR), Constantin, Cristian9 (AUTHOR), Popescu, Dragoş-Marian10 (AUTHOR), Streba, Costin Teodor11,12 (AUTHOR) costin.streba@umfcv.ro, Vere, Cristin Constantin1,2 (AUTHOR)
Publikováno v: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 18, p5616. 17p.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Anti-tumour activity of tachykinin NK1receptor antagonists on human glioma U373 MG xenograft.
Autor: Palma, C, Bigioni, M, Irrissuto, C, Nardelli, F, Maggi, C A, Manzini, S
Publikováno v: British Journal of Cancer; 1/15/2000, Vol. 82 Issue 2, p480, 8p
Zobrazit plný text záznamu
8
Akademický článek
Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety.
Autor: Animati F; Menarini Ricerche Pomezia, via Tito Speri 10, 00040 Pomezia (Rome), Italy., Berettoni M, Bigioni M, Binaschi M, Cipollone A, Irrissuto C, Nardelli F, Olivieri L
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2012 Aug 01; Vol. 22 (15), pp. 5013-7. Date of Electronic Publication: 2012 Jun 15.
Zobrazit plný text záznamu
9
Akademický článek
Induction of a less aggressive phenotype in human colon carcinoma HCT116 cells by chronic exposure to HDAC inhibitor SAHA.
Autor: Bressan A; Department of Pharmacology, Menarini Ricerche, Pomezia, Rome, Italy., Bigioni M, Bellarosa D, Nardelli F, Irrissuto C, Maggi CA, Binaschi M
Publikováno v: Oncology reports [Oncol Rep] 2010 Nov; Vol. 24 (5), pp. 1249-55.
Zobrazit plný text záznamu
10
Akademický článek
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.
Autor: Sánchez, Manuel Lisardo1 (AUTHOR) lisardosanchez8@gmail.com, Rodríguez, Francisco D.2,3 (AUTHOR) lario@usal.es, Coveñas, Rafael1,3 (AUTHOR) covenas@usal.es
Publikováno v: Cancers. Mar2023, Vol. 15 Issue 6, p1694. 63p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje